The latest developments in the field of lung cancer were discussed last week in Barcelona (Spain) during the 20th edition of the World Conference on Lung Cancer organized by the International Association for the Study of Lung Cancer (IASLC). The focus of clinical studies ranged from screening to treatment of advanced disease. [more]
May was awash with news stories about blood tests for prostate cancer. Reports that a new serum test called IsoPSA could predict prostate cancer more precisely than conventional PSA testing brought obvious interest. The new [more]
Delaying treatment for a curable prostate cancer is an increasingly popular option among men with low risk tumours. Simon Crompton looks at efforts to learn more about who benefits and how to avoid delaying too [more]